2432 related articles for article (PubMed ID: 19832114)
1. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
4. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.
Shapiro RL; Thior I; Gilbert PB; Lockman S; Wester C; Smeaton LM; Stevens L; Heymann SJ; Ndung'u T; Gaseitsiwe S; Novitsky V; Makhema J; Lagakos S; Essex M
AIDS; 2006 Jun; 20(9):1281-8. PubMed ID: 16816557
[TBL] [Abstract][Full Text] [Related]
5. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
6. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
7. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
8. Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.
Omer SB;
AIDS; 2011 Mar; 25(6):767-76. PubMed ID: 21330912
[TBL] [Abstract][Full Text] [Related]
9. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
11. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
[TBL] [Abstract][Full Text] [Related]
12. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
[TBL] [Abstract][Full Text] [Related]
13. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
Jamieson DJ; Chasela CS; Hudgens MG; King CC; Kourtis AP; Kayira D; Hosseinipour MC; Kamwendo DD; Ellington SR; Wiener JB; Fiscus SA; Tegha G; Mofolo IA; Sichali DS; Adair LS; Knight RJ; Martinson F; Kacheche Z; Soko A; Hoffman I; van der Horst C;
Lancet; 2012 Jun; 379(9835):2449-2458. PubMed ID: 22541418
[TBL] [Abstract][Full Text] [Related]
14. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
[TBL] [Abstract][Full Text] [Related]
15. Coverage of highly active antiretroviral therapy among postpartum women in Malawi.
Kumwenda J; Matchere F; Mataya R; Chen S; Mipando L; Li Q; Kumwenda NI; Taha TE
Int J STD AIDS; 2011 Jul; 22(7):368-72. PubMed ID: 21729953
[TBL] [Abstract][Full Text] [Related]
16. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
[TBL] [Abstract][Full Text] [Related]
17. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
Palacios R; Senise J; Vaz M; Diaz R; Castelo A
HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
[TBL] [Abstract][Full Text] [Related]
18. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
[TBL] [Abstract][Full Text] [Related]
20. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]